Literature DB >> 24903093

Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes.

Siroon Bekkering1, Jessica Quintin1, Leo A B Joosten1, Jos W M van der Meer1, Mihai G Netea1, Niels P Riksen2.   

Abstract

OBJECTIVE: Although the role of monocytes in the pathogenesis of atherosclerosis is well established, the persistent vascular inflammation remains largely unexplained. Recently, our group reported that stimulation of monocytes with various microbial products can induce a long-lasting proinflammatory phenotype via epigenetic reprogramming, a process termed trained immunity. We now hypothesize that oxidized low-density lipoprotein (oxLDL) also induces a long-lasting proinflammatory phenotype in monocytes, which accelerates atherosclerosis by proinflammatory cytokine production and foam cell formation. APPROACH AND
RESULTS: Isolated human monocytes were exposed for 24 hours to medium or oxLDL. After washing and resting for 6 days, the cells were exposed to toll-like receptor 2 and 4 agonists. Pre-exposure to oxLDL increased mRNA expression and protein formation on toll-like receptor 2 and 4 stimulation of several proatherogenic proteins, including interleukin-6, interleukin-18, interleukin-8, tumor necrosis factor-α, monocyte chemoattractant protein 1, and matrix metalloproteinase 2 and 9. In addition, foam cell formation was enhanced after oxLDL exposure, which was associated with an upregulation of scavenger receptors CD36 and scavenger receptor-A and downregulation of ATP-binding cassette transporters, ABCA1 and ABCG1. Chromatin immunoprecipitation performed 6 days after oxLDL stimulation demonstrated increased trimethylation of lysine 4 at histone 3 in promoter regions of tnfα, il-6, il-18, mcp-1, mmp2, mmp9, cd36, and sr-a. Finally, pretreatment of the monocytes with the histone methyltransferase inhibitor methylthioadenosine completely prevented the oxLDL-induced long-lasting proinflammatory phenotype.
CONCLUSIONS: Brief exposure of monocytes to a low concentration of oxLDL induces a long-lasting proatherogenic macrophage phenotype via epigenetic histone modifications, characterized by increased proinflammatory cytokine production and foam cell formation.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; epigenomics; inflammation; monocytes; oxidized low-density lipoprotein

Mesh:

Substances:

Year:  2014        PMID: 24903093     DOI: 10.1161/ATVBAHA.114.303887

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  176 in total

Review 1.  Immune defence against Candida fungal infections.

Authors:  Mihai G Netea; Leo A B Joosten; Jos W M van der Meer; Bart-Jan Kullberg; Frank L van de Veerdonk
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

Review 2.  Therapeutic targeting of trained immunity.

Authors:  Willem J M Mulder; Jordi Ochando; Leo A B Joosten; Zahi A Fayad; Mihai G Netea
Journal:  Nat Rev Drug Discov       Date:  2019-07       Impact factor: 84.694

Review 3.  Potential contributions of intimal and plaque hypoxia to atherosclerosis.

Authors:  Guo-Hua Fong
Journal:  Curr Atheroscler Rep       Date:  2015-06       Impact factor: 5.113

Review 4.  Immunometabolic Crosstalk: An Ancestral Principle of Trained Immunity?

Authors:  Sider Penkov; Ioannis Mitroulis; George Hajishengallis; Triantafyllos Chavakis
Journal:  Trends Immunol       Date:  2018-11-29       Impact factor: 16.687

Review 5.  Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology.

Authors:  Daniel F J Ketelhuth; Esther Lutgens; Magnus Bäck; Christoph J Binder; Jan Van den Bossche; Carolin Daniel; Ingrid E Dumitriu; Imo Hoefer; Peter Libby; Luke O'Neill; Christian Weber; Paul C Evans
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

6.  Immune cells that remember inflammation could offer treatment targets for atherosclerosis.

Authors:  Amanda B Keener
Journal:  Nature       Date:  2021-06       Impact factor: 49.962

7.  Urban living in healthy Tanzanians is associated with an inflammatory status driven by dietary and metabolic changes.

Authors:  Godfrey S Temba; Vesla Kullaya; Tal Pecht; Blandina T Mmbaga; Anna C Aschenbrenner; Thomas Ulas; Gibson Kibiki; Furaha Lyamuya; Collins K Boahen; Vinod Kumar; Leo A B Joosten; Joachim L Schultze; Andre J van der Ven; Mihai G Netea; Quirijn de Mast
Journal:  Nat Immunol       Date:  2021-02-11       Impact factor: 25.606

8.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

9.  Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.

Authors:  Fleur M van der Valk; Siroon Bekkering; Jeffrey Kroon; Calvin Yeang; Jan Van den Bossche; Jaap D van Buul; Amir Ravandi; Aart J Nederveen; Hein J Verberne; Corey Scipione; Max Nieuwdorp; Leo A B Joosten; Mihai G Netea; Marlys L Koschinsky; Joseph L Witztum; Sotirios Tsimikas; Niels P Riksen; Erik S G Stroes
Journal:  Circulation       Date:  2016-08-05       Impact factor: 29.690

Review 10.  The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach.

Authors:  Frederick O Cope; Bonnie Abbruzzese; James Sanders; Wendy Metz; Kristyn Sturms; David Ralph; Michael Blue; Jane Zhang; Paige Bracci; Wiam Bshara; Spencer Behr; Toby Maurer; Kenneth Williams; Joshua Walker; Allison Beverly; Brooke Blay; Anirudh Damughatla; Mark Larsen; Courtney Mountain; Erin Neylon; Kaeli Parcel; Kapil Raghuraman; Kevin Ricks; Lucas Rose; Akhilesh Sivakumar; Nicholas Streck; Bryan Wang; Christopher Wasco; Larry S Schlesinger; Abul Azad; Murugesan V S Rajaram; Wael Jarjour; Nicholas Young; Thomas Rosol; Amifred Williams; Michael McGrath
Journal:  Nucl Med Biol       Date:  2015-12-03       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.